Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hepatology

Inside the ICU: Standard Treatments and Technologies

At a Glance

In the ICU, acute liver failure is managed by a multidisciplinary team focused on preventing brain swelling and supporting failing organs. Key treatments include N-acetylcysteine (NAC) and bridging therapies like plasma exchange and continuous renal replacement therapy (CRRT).

The care of a patient with Acute Liver Failure (ALF) is among the most complex in all of medicine. Because the liver affects every other organ, treatment requires a highly coordinated, multidisciplinary ICU team. While the liver is given time to rest and hopefully regenerate, the medical team “takes over” the functions of the failing organs using advanced medications and machines [1][2].

Protecting the Brain: Managing Edema

The most critical task in the ICU is preventing cerebral edema (brain swelling) [3]. When the brain swells within the rigid skull, it can cause permanent damage or death. Doctors use a protocolized approach to keep pressure low:

  • Mannitol: This is often the first-line medication used to “pull” fluid out of the brain tissue and into the bloodstream to be flushed out [4].
  • Hypertonic Saline: Doctors may give concentrated salt water to keep the patient’s sodium levels high-normal (usually between 145 and 155 mEq/L). This higher sodium level helps prevent water from entering the brain cells and causing them to swell [4].
  • Temperature Control: Even a mild fever can increase the risk of brain swelling. The team may use cooling blankets or medications to maintain a normal or slightly cool body temperature [3][5].

Key Medications: N-acetylcysteine (NAC)

N-acetylcysteine (NAC) is the gold-standard treatment for acetaminophen (Tylenol) overdose [6]. However, it is also widely used “off-label” for ALF caused by other factors, such as viruses or drug reactions [7][8].
Research suggests that NAC may improve blood flow to the liver and provide antioxidant support, which can help the liver recover or keep the patient stable enough to reach a transplant [9][10]. While its benefit in non-Tylenol cases is still debated by some experts, many specialized centers include it as a standard part of their early treatment protocol [11][12].

“Bridging” Therapies: Plasma Exchange and CRRT

When the liver is too sick to clear toxins on its own, doctors may use “extracorporeal” (outside the body) therapies to bridge the gap to recovery or transplant:

  • Therapeutic Plasma Exchange (TPE): Also known as plasmapheresis, this involves removing the patient’s plasma (which is full of toxins and inflammatory “cytokines”) and replacing it with healthy donor plasma [13][14]. TPE has been shown to improve survival and stabilize blood pressure in ALF patients [15][16].
  • Continuous Renal Replacement Therapy (CRRT): This is a 24-hour-a-day form of dialysis. In ALF, it is used not just for kidney failure, but also to continuously filter out ammonia from the blood to protect the brain [17][18].

The Multidisciplinary Team

In a specialized liver ICU, your care is managed by a large group of experts working in concert:

  • Hepatologists: Liver specialists who manage the underlying disease and transplant evaluation.
  • Intensivists: ICU doctors who manage the ventilator, blood pressure, and sedation.
  • Nephrologists: Kidney specialists who manage dialysis (CRRT) [17].
  • Neurologists: Brain specialists who monitor for signs of swelling or seizures [3].
  • Transplant Surgeons: Experts who are on standby to perform surgery if medical management cannot save the native liver [1].
  • Social Workers & Palliative Care Teams: These professionals provide a standard layer of family support in the ICU. Their involvement is not a sign of “giving up,” but rather a crucial resource for navigating complex hospital systems, emotional strain, and difficult medical decisions [19].

Common questions in this guide

Why is N-acetylcysteine (NAC) used for acute liver failure?
NAC is the standard treatment for acetaminophen overdoses, but it is also used for other types of liver failure. It provides antioxidant support and improves blood flow to the liver, helping it recover or keeping the patient stable until transplant.
How do doctors prevent brain swelling in acute liver failure?
The ICU team uses medications like mannitol or hypertonic saline to draw excess fluid away from the brain. They also closely monitor and control the patient's body temperature using cooling blankets, as even a mild fever can worsen swelling.
What is the purpose of Continuous Renal Replacement Therapy (CRRT)?
CRRT is a gentle, 24-hour form of dialysis used in the ICU. For liver failure patients, it not only supports failing kidneys but also continuously filters dangerous ammonia out of the blood to protect the brain from damage.
How does therapeutic plasma exchange (plasmapheresis) help?
Also known as plasmapheresis, therapeutic plasma exchange removes the patient's toxic plasma and replaces it with healthy donor plasma. It acts as a bridge to stabilize blood pressure and remove inflammatory proteins while waiting for liver recovery or a transplant.
Which doctors make up the ICU team for liver failure?
Because liver failure affects every organ, care requires specialists working together. The team typically includes hepatologists (liver specialists), intensivists (critical care doctors), nephrologists (kidney specialists), neurologists, and transplant surgeons.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is the patient receiving N-acetylcysteine (NAC), and what is the intended goal for its use in this specific case?
  2. 2.What are the current targets for the patient's blood sodium levels and temperature to help protect the brain from swelling?
  3. 3.If the patient's ammonia levels are high, are we using Continuous Renal Replacement Therapy (CRRT) or Plasma Exchange to lower them?
  4. 4.How are you monitoring for intracranial hypertension, and at what point would we consider more invasive monitoring?
  5. 5.What are the 'red flags' you are watching for in the next 12–24 hours that would indicate the current medical management is failing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    'Fulminant hepatic failure' anesthesiologic considerations.

    Vetrugno L, Alessandri F, Toscano A, et al.

    Current opinion in anaesthesiology 2025; (38(4)):503-512 doi:10.1097/ACO.0000000000001530.

    PMID: 40511630
  2. 2

    Acute liver failure.

    Vasques F, Cavazza A, Bernal W

    Current opinion in critical care 2022; (28(2)):198-207 doi:10.1097/MCC.0000000000000923.

    PMID: 35142727
  3. 3

    What you need to know about: acute liver failure.

    Matthewman MC, Warrillow S

    British journal of hospital medicine (London, England : 2005) 2022; (83(9)):1-11 doi:10.12968/hmed.2022.0051.

    PMID: 36193917
  4. 4

    Acute Liver Failure.

    Bunchorntavakul C, Reddy KR

    Clinics in liver disease 2017; (21(4)):769-792 doi:10.1016/j.cld.2017.06.002.

    PMID: 28987262
  5. 5

    A case report of full recovery from severe cerebral edema secondary to acetaminophen-induced hepatotoxicity in a 13 year old girl.

    Austin EB, Hobbs H, Crouse BA, Lobos AT

    BMC pediatrics 2018; (18(1)):247 doi:10.1186/s12887-018-1233-5.

    PMID: 30060738
  6. 6

    Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure.

    Bunchorntavakul C, Reddy KR

    Clinics in liver disease 2018; (22(2)):325-346 doi:10.1016/j.cld.2018.01.007.

    PMID: 29605069
  7. 7

    Impact of Duration of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure.

    Bass SN, Lumpkin M, Mireles-Cabodevila E, et al.

    Critical care explorations 2021; (3(5)):e0411 doi:10.1097/CCE.0000000000000411.

    PMID: 34036270
  8. 8

    N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.

    Siu JT, Nguyen T, Turgeon RD

    The Cochrane database of systematic reviews 2020; (12()):CD012123 doi:10.1002/14651858.CD012123.pub2.

    PMID: 33294991
  9. 9

    Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.

    Nabi T, Nabi S, Rafiq N, Shah A

    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2017; (23(3)):169-175 doi:10.4103/1319-3767.207711.

    PMID: 28611340
  10. 10

    N-acetylcysteine for non-acetaminophen induced acute liver failure: A review.

    Jiang SX, Hussaini T, Yoshida EM

    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2022; (28(2)):85-91 doi:10.4103/sjg.sjg_406_21.

    PMID: 35142656
  11. 11

    Use of Oral N-Acetylcysteine (NAC) in Non-Acetaminophen-Induced Acute Hepatic Failure.

    Sharieff S, Idrees A, Rafai W, Bukhari SUS

    Cureus 2023; (15(3)):e35852 doi:10.7759/cureus.35852.

    PMID: 37033589
  12. 12

    Evaluation and treatment of acetaminophen toxicity.

    Fisher ES, Curry SC

    Advances in pharmacology (San Diego, Calif.) 2019; (85()):263-272 doi:10.1016/bs.apha.2018.12.004.

    PMID: 31307590
  13. 13

    Effectiveness of High-Volume Therapeutic Plasma Exchange for Acute and Acute-on-Chronic Liver Failure in Korean Pediatric Patients.

    Lim H, Kang Y, Park S, Koh H

    Pediatric gastroenterology, hepatology & nutrition 2022; (25(6)):481-488 doi:10.5223/pghn.2022.25.6.481.

    PMID: 36451692
  14. 14

    Comparative Analysis of Plasmapheresis Versus Plasmapheresis Combined With Continuous Renal Replacement Therapy in Adult Liver Failure: A Retrospective Observational Study.

    Ocak I, Colak M, Bilici BN

    Transplantation proceedings 2025; (57(4)):598-605 doi:10.1016/j.transproceed.2025.02.051.

    PMID: 40102129
  15. 15

    Therapeutic plasma exchange in acute on chronic liver failure.

    Stahl K, Busch M, Fuge J, et al.

    Journal of clinical apheresis 2020; (35(4)):316-327 doi:10.1002/jca.21799.

    PMID: 32583446
  16. 16

    Therapeutic plasma exchange in liver failure.

    Chris-Olaiya A, Kapoor A, Ricci KS, Lindenmeyer CC

    World journal of hepatology 2021; (13(8)):904-915 doi:10.4254/wjh.v13.i8.904.

    PMID: 34552697
  17. 17

    Effect of Continuous Renal Replacement Therapy on Outcome in Pediatric Acute Liver Failure.

    Deep A, Stewart CE, Dhawan A, Douiri A

    Critical care medicine 2016; (44(10)):1910-9 doi:10.1097/CCM.0000000000001826.

    PMID: 27347761
  18. 18

    A 15-Year Retrospective Study of Supportive Extracorporeal Therapies Including Plasma Exchange and Continuous Venovenous Hemodiafiltration of 114 Adults with Acute Liver Failure Awaiting Liver Transplantation.

    Ocak I

    Annals of transplantation 2023; (28()):e939745 doi:10.12659/AOT.939745.

    PMID: 37365780
  19. 19

    Nonacetaminophen Drug-Induced Acute Liver Failure.

    Thomas AM, Lewis JH

    Clinics in liver disease 2018; (22(2)):301-324 doi:10.1016/j.cld.2018.01.006.

    PMID: 29605068

This page explains ICU treatments for acute liver failure for educational purposes only. Always consult the critical care team regarding your loved one's specific medical management and prognosis.

Get notified when new evidence is published on Acute liver failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.